Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.
GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.
A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.
PBM transparency gives employers greater visibility into pharmacy costs—but disclosure is only the beginning. Learn how plan sponsors can turn better information into greater control, accountability, and measurable results.
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Menopause affects productivity, retention, and healthcare costs. Learn why pharmacy benefit design is central to effective menopause support.
Healthcare affordability is not just about price. Learn what patients experience at the pharmacy counter and why unpredictability erodes trust.